Breast carcinomas occurring in young women (< 35 years) are different

References 33

1. 1.

   Adami H. O., Malker B., Holmberg L., Persson I., Stone B. The relation between survival and age at diagnosis in breast cancer. N Engl J Med. 1986;315(9):559-563.

   Not in our library10.1056/nejm198608283150906 (opens in a new tab)

2. 2.

   Albain K. S., Allred D. C., Clark G. M. Breast cancer outcome and predictors of outcome: are there age differentials? J Natl Cancer Inst Monogr. 1994;(16):35-42.

   Not in our library

3. 3.

   Allred D. C., Clark G. M., Molina R., Tandon A. K., Schnitt S. J., Gilchrist K. W., Osborne C. K., Tormey D. C., McGuire W. L. Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer. Hum Pathol. 1992;23(9):974-979.

   Not in our library10.1016/0046-8177(92)90257-4 (opens in a new tab)

4. 4.

   Barnes D. M., Dublin E. A., Fisher C. J., Levison D. A., Millis R. R. Immunohistochemical detection of p53 protein in mammary carcinoma: an important new independent indicator of prognosis? Hum Pathol. 1993;24(5):469-476.

   Not in our library10.1016/0046-8177(93)90158-d (opens in a new tab)

5. 5.

   Bonnier P., Romain S., Charpin C., Lejeune C., Tubiana N., Martin P. M., Piana L. Age as a prognostic factor in breast cancer: relationship to pathologic and biologic features. Int J Cancer. 1995;62(2):138-144.

   Not in our library10.1002/ijc.2910620205 (opens in a new tab)

6. 6.

   Caleffi M., Teague M. W., Jensen R. A., Vnencak-Jones C. L., Dupont W. D., Parl F. F. p53 gene mutations and steroid receptor status in breast cancer. Clinicopathologic correlations and prognostic assessment. Cancer. 1994;73(8):2147-2156.

   Not in our library10.1002/1097-0142(19940415)73:8<2147::aid-cncr2820730820>3.0.co;2-5 (opens in a new tab)

7. 7.

   Cattoretti G., Becker M. H., Key G., Duchrow M., Schlüter C., Galle J., Gerdes J. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol. 1992;168(4):357-363.

   Not in our library10.1002/path.1711680404 (opens in a new tab)

8. 8.

   Chung M., Chang H. R., Bland K. I., Wanebo H. J. Younger women with breast carcinoma have a poorer prognosis than older women. Cancer. 1996;77(1):97-103.

   Not in our library10.1002/(sici)1097-0142(19960101)77:1<97::aid-cncr16>3.0.co;2-3 (opens in a new tab)

9. 9.

   Elston C. W., Ellis I. O. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 1991;19(5):403-410.

   Not in our library10.1111/j.1365-2559.1991.tb00229.x (opens in a new tab)

10. 10.

    Eyfjörd J. E., Thorlacius S., Steinarsdottir M., Valgardsdottir R., Ogmundsdottir H. M., Anamthawat-Jonsson K. p53 abnormalities and genomic instability in primary human breast carcinomas. Cancer Res. 1995;55(3):646-651.

    Not in our library

11. 11.

    Foekens J. A., Portengen H., van Putten W. L., Peters H. A., Krijnen H. L., Alexieva-Figusch J., Klijn J. G. Prognostic value of estrogen and progesterone receptors measured by enzyme immunoassays in human breast tumor cytosols. Cancer Res. 1989;49(21):5823-5828.

    Not in our library

12. 12.
    c-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes · 1991

    No notice
13. 13.

    Høst H., Lund E. Age as a prognostic factor in breast cancer. Cancer. 1986;57(11):2217-2221.

    Not in our library10.1002/1097-0142(19860601)57:11<2217::aid-cncr2820571124>3.0.co;2-t (opens in a new tab)

14. 14.

    Jacquemier J., Molès J. P., Penault-Llorca F., Adélaide J., Torrente M., Viens P., Birnbaum D., Theillet C. p53 immunohistochemical analysis in breast cancer with four monoclonal antibodies: comparison of staining and PCR-SSCP results. Br J Cancer. 1994;69(5):846-852.

    Not in our library10.1038/bjc.1994.164 (opens in a new tab)

15. 15.

    Kuerbitz S. J., Plunkett B. S., Walsh W. V., Kastan M. B. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc Natl Acad Sci U S A. 1992;89(16):7491-7495.

    Not in our library10.1073/pnas.89.16.7491 (opens in a new tab)

16. 16.

    Marcus J. N., Watson P., Page D. L., Lynch H. T. Pathology and heredity of breast cancer in younger women. J Natl Cancer Inst Monogr. 1994;(16):23-34.

    Not in our library

17. 17.

    Mazars R., Spinardi L., BenCheikh M., Simony-Lafontaine J., Jeanteur P., Theillet C. p53 mutations occur in aggressive breast cancer. Cancer Res. 1992;52(14):3918-3923.

    Not in our library

18. 18.

    Noyes R. D., Spanos W. J., Montague E. D. Breast cancer in women aged 30 and under. Cancer. 1982;49(6):1302-1307.

    Not in our library10.1002/1097-0142(19820315)49:6<1302::aid-cncr2820490638>3.0.co;2-0 (opens in a new tab)

19. 19.

    Pillers E. M. Histological grade of breast cancer in younger women. Lancet. 1992;339(8807):1483-1483.

    Not in our library10.1016/0140-6736(92)92079-u (opens in a new tab)

20. 20.

    Railo M., Nordling S., von Boguslawsky K., Leivonen M., Kyllönen L., von Smitten K. Prognostic value of Ki-67 immunolabelling in primary operable breast cancer. Br J Cancer. 1993;68(3):579-583.

    Not in our library10.1038/bjc.1993.389 (opens in a new tab)

21. 21.

    Rajakariar R., Walker R. A. Pathological and biological features of mammographically detected invasive breast carcinomas. Br J Cancer. 1995;71(1):150-154.

    Not in our library10.1038/bjc.1995.31 (opens in a new tab)

22. 22.

    Rasmussen B. B., Rose C., Thorpe S. M., Hou-Jensen K., Daehnfeldt J. L., Palshof T. Histopathological characteristics and oestrogen receptor content in primary breast carcinoma. Virchows Arch A Pathol Anat Histol. 1981;390(3):347-351.

    Not in our library10.1007/bf00496564 (opens in a new tab)

23. 23.

    Reiner A., Neumeister B., Spona J., Reiner G., Schemper M., Jakesz R. Immunocytochemical localization of estrogen and progesterone receptor and prognosis in human primary breast cancer. Cancer Res. 1990;50(21):7057-7061.

    Not in our library

24. 24.

    Ribeiro G. G., Swindell R. The prognosis of breast carcinoma in women aged less than 40 years. Clin Radiol. 1981;32(2):231-236.

    Not in our library10.1016/s0009-9260(81)80168-7 (opens in a new tab)

25. 25.

    Sant M., Gatta G., Micheli A., Verdecchia A., Capocaccia R., Crosignani P., Berrino F. Survival and age at diagnosis of breast cancer in a population-based cancer registry. Eur J Cancer. 1991;27(8):981-984.

    Not in our library10.1016/0277-5379(91)90263-d (opens in a new tab)

26. 26.

    Thor A. D., Moore DH I. I., Edgerton S. M., Kawasaki E. S., Reihsaus E., Lynch H. T., Marcus J. N., Schwartz L., Chen L. C., Mayall B. H. Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers. J Natl Cancer Inst. 1992;84(11):845-855.

    Not in our library10.1093/jnci/84.11.845 (opens in a new tab)

27. 27.

    Walker R. A., Camplejohn R. S. Comparison of monoclonal antibody Ki-67 reactivity with grade and DNA flow cytometry of breast carcinomas. Br J Cancer. 1988;57(3):281-283.

    Not in our library10.1038/bjc.1988.60 (opens in a new tab)

28. 28.

    Walker R. A., Gullick W. J., Varley J. M. An evaluation of immunoreactivity for c-erbB-2 protein as a marker of poor short-term prognosis in breast cancer. Br J Cancer. 1989;60(3):426-429.

    Not in our library10.1038/bjc.1989.299 (opens in a new tab)

29. 29.

    Wallgren A., Silfverswärd C., Hultborn A. Carcinoma of the breast in women under 30 years of age: a clinical and histopathological study of all cases reported as carcinoma to the Swedish Cancer Registry, 1958-1968. Cancer. 1977;40(2):916-923.

    Not in our library10.1002/1097-0142(197708)40:2<916::aid-cncr2820400248>3.0.co;2-1 (opens in a new tab)

30. 30.

    Wynford-Thomas D. P53 in tumour pathology: can we trust immunocytochemistry? J Pathol. 1992;166(4):329-330.

    Not in our library10.1002/path.1711660402 (opens in a new tab)

31. 31.

    Yin Y., Tainsky M. A., Bischoff F. Z., Strong L. C., Wahl G. M. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell. 1992;70(6):937-948.

    Not in our library10.1016/0092-8674(92)90244-7 (opens in a new tab)

32. 32.

    de la Rochefordiere A., Asselain B., Campana F., Scholl S. M., Fenton J., Vilcoq J. R., Durand J. C., Pouillart P., Magdelenat H., Fourquet A. Age as prognostic factor in premenopausal breast carcinoma. Lancet. 1993;341(8852):1039-1043.

    Not in our library10.1016/0140-6736(93)92407-k (opens in a new tab)

33. 33.

    el-Deiry W. S., Harper J. W., O'Connor P. M., Velculescu V. E., Canman C. E., Jackman J., Pietenpol J. A., Burrell M., Hill D. E., Wang Y. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res. 1994;54(5):1169-1174.

    Not in our library

Cited by papers we hold 3

• Breast Cancer in Young Women: Poor Survival Despite Intensive Treatment · 2009
  No notice
• Breast cancer risk by age at birth, time since birth and time intervals between births: exploring interaction effects · 2004
  No notice
• Young age: an independent risk factor for disease-free survival in women with operable breast cancer · 2004
  No notice

Questions about this paper

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.